Skip to main navigation Skip to search Skip to main content

A Phase II study of Vorinostat (MK-0683) in Patients with Primary Myelofibrosis (PMF) and Post-Polycythaemia Vera Myelofibrosis (PPV-MF)

  • Christen Lykkegaard Andersen
  • , Nanna Mortensen
  • , Hanne Vestergaard
  • , Ole W Bjerrum
  • , Tobias Klausen
  • , Hans Carl Hasselbalch
  • Roskilde Sygehus
  • Rigshospitalet
  • Herlev Hospital

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Original languageEnglish
Publication date14. Jun 2013
Publication statusPublished - 14. Jun 2013
EventEHA 18th Congress - Stockholm, Sweden
Duration: 13. Jun 201316. Jun 2013

Conference

ConferenceEHA 18th Congress
Country/TerritorySweden
CityStockholm
Period13/06/201316/06/2013

Cite this